Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Oct;23(10):1761-7.
doi: 10.1007/s00467-007-0616-x. Epub 2007 Sep 30.

The thrombotic microangiopathies

Affiliations
Review

The thrombotic microangiopathies

Lawrence Copelovitch et al. Pediatr Nephrol. 2008 Oct.

Abstract

The term thrombotic microangiopathy (TMA) encompasses a group of conditions that are defined by, or result from, a similar histopathological lesion. Hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), and several other conditions are associated with TMA. Distinguishing HUS from TTP is not always possible unless there are specific causes, such as Shiga toxin, Streptococcus pneumoniae, or a specific molecular defect such as factor H or ADAMTS13 deficiency. This review describes the forms of HUS/TTP that are not related to Shiga toxin, pneumococcal infection, genetic causes, or ADAMTS13 deficiency. Conditions include HUS/TTP associated with autoimmune disorders, human immunodeficiency virus (HIV) infection, transplantation, malignancy, and medications.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Thrombotic microangiopathies

Similar articles

Cited by

References

    1. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB, European Paediatric Research Group for HUS A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70:423–431. - PubMed
    1. Symmers W. Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy) BMJ. 1952;ii:897–903. - PMC - PubMed
    1. George JN, Selby GB. Thrombotic microangiopathy after allogenic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes. Bone Marrow Transplant. 2004;33:1073–1074. - PubMed
    1. Tsai HM. Molecular mechanisms in thrombotic thrombocytopenic purpura. Semin Thromb Hemost. 2004;30:549–557. - PubMed
    1. McLeod BC. Thrombotic microangiopathies in bone marrow and organ transplant patients. J Clin Apheresis. 2002;17:118–123. - PubMed

MeSH terms